Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Literature DB >> 26712681

Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Roberto García-Figueiras¹, Sandra Baleato-González, Anwar R Padhani, Laura Oleaga, Joan C Vilanova, Antonio Luna, Juan Carlos Cobas Gómez.

Abstract

Abnormal metabolism is a key tumor hallmark. Proton magnetic resonance spectroscopy (1H-MRS) allows measurement of metabolite concentration that can be utilized to characterize tumor metabolic changes. 1H-MRS measurements of specific metabolites have been implemented in the clinic. This article performs a systematic review of image acquisition and interpretation of 1H-MRS for cancer evaluation, evaluates its strengths and limitations, and correlates metabolite peaks at 1H-MRS with diagnostic and prognostic parameters of cancer in different tumor types.

Entities: Chemical Disease

Mesh：

Year: 2016 PMID： 26712681 PMCID： PMC4712903 DOI： 10.5152/dir.2015.15009

Source DB: PubMed Journal: Diagn Interv Radiol ISSN： 1305-3825 Impact factor: 2.630

74 in total

1. In vivo proton MRS of normal pancreas metabolites during breath-holding and free-breathing.

Authors: T-H Su; E-H Jin; H Shen; Y Zhang; W He
Journal: Clin Radiol Date: 2012-02-07 Impact factor: 2.350

2. In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites.

Authors: Pravat K Mandal
Journal: Eur J Radiol Date: 2011-04-22 Impact factor: 3.528

Review 3. In vivo magnetic resonance spectroscopy of liver tumors and metastases.

Authors: E G W ter Voert; L Heijmen; H W M van Laarhoven; A Heerschap
Journal: World J Gastroenterol Date: 2011-12-21 Impact factor: 5.742

4. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Authors: F Russo; S Mazzetti; G Grignani; G De Rosa; M Aglietta; G C Anselmetti; M Stasi; D Regge
Journal: Eur Radiol Date: 2011-12-04 Impact factor: 5.315

Review 5. MR imaging of treated prostate cancer.

Authors: Hebert Alberto Vargas; Cecilia Wassberg; Oguz Akin; Hedvig Hricak
Journal: Radiology Date: 2012-01 Impact factor: 11.105

Review 6. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.

Authors: Ty K Subhawong; Xin Wang; Daniel J Durand; Michael A Jacobs; John A Carrino; Antonio J Machado; Laura M Fayad
Journal: AJR Am J Roentgenol Date: 2012-01 Impact factor: 3.959

Review 7. Molecular imaging of cancer: MR spectroscopy and beyond.

Authors: K Pinker; A Stadlbauer; W Bogner; S Gruber; T H Helbich
Journal: Eur J Radiol Date: 2010-06-04 Impact factor: 3.528

8. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions.

Authors: E J Delikatny; P Russell; J C Hunter; R Hancock; K H Atkinson; C van Haaften-Day; C E Mountford
Journal: Radiology Date: 1993-09 Impact factor: 11.105

9. ESUR prostate MR guidelines 2012.

Authors: Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal: Eur Radiol Date: 2012-02-10 Impact factor: 5.315

10. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.

Authors: E Kousi; I Tsougos; K Vasiou; K Theodorou; A Poultsidi; I Fezoulidis; C Kappas
Journal: ScientificWorldJournal Date: 2012-05-03

14 in total

1. ¹H-MRS application in the evaluation of response to photo-thermal therapy using iron oxide-gold core-shell nanoparticles, an in vivo study.

Authors: Sina Ehsani; Erfan Saatchian; Abolfazl Sarikhani; Alireza Montazerabadi
Journal: Photochem Photobiol Sci Date: 2021-02-09 Impact factor: 3.982

2. Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.

Authors: Bang-Bin Chen; Yen-Shen Lu; Chih-Wei Yu; Ching-Hung Lin; Tom Wei-Wu Chen; Shwu-Yuan Wei; Ann-Lii Cheng; Tiffany Ting-Fang Shih
Journal: Eur Radiol Date: 2018-05-16 Impact factor: 5.315

Review 3. Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.

Authors: Fulvio Zaccagna; James T Grist; Surrin S Deen; Ramona Woitek; Laura Mt Lechermann; Mary A McLean; Bristi Basu; Ferdia A Gallagher
Journal: Br J Radiol Date: 2018-01-19 Impact factor: 3.039

Review 4. Background, current role, and potential applications of radiogenomics.

Authors: Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal: J Magn Reson Imaging Date: 2017-11-02 Impact factor: 4.813

5. Metabolic Alterations in Sputum and Exhaled Breath Condensate of Early Stage Non-Small Cell Lung Cancer Patients After Surgical Resection: A Pilot Study.

Authors: Naseer Ahmed; Biniam Kidane; Le Wang; Zoann Nugent; Nataliya Moldovan; April McElrea; Shiva Shariati-Ievari; Gefei Qing; Lawrence Tan; Gordon Buduhan; Sadeesh K Srinathan; Renelle Meyers; Michel Aliani
Journal: Front Oncol Date: 2022-06-03 Impact factor: 5.738

6. Revisiting the use of proton magnetic resonance spectroscopy in distinguishing between primary and secondary malignant tumors of the central nervous system.

Authors: Milena K Farche; Natalia O Fachinetti; Luciana Rp da Silva; Larissa A Matos; Simone Appenzeller; Fernando Cendes; Fabiano Reis
Journal: Neuroradiol J Date: 2022-04-21